Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 4 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Pathologic Complete Response 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 HER2-negative Breast Cancer 1 Gastric Adenocarcinoma 1 Carcinoma, Small Cell 1 Breast Diseases 1 Brain Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Cisplatin 178 Paclitaxel 79 Radiotherapy 76 Carboplatin 70 Brachytherapy 69 pembrolizumab 63 Bevacizumab 40 Gemcitabine 28 Radiation 27 Topotecan 26 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25 Nivolumab 22 Colposcopy 22 human papillomavirus vaccine, L1 type 16, 18 21 Magnetic Resonance Spectroscopy 21 Drug Therapy 20 atezolizumab 19 Platinum 19 Papillomavirus Vaccines 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Taxes 16 Cyclophosphamide 16 Biopsy 16 Early Intervention, Educational 15 1,2-diaminocyclohexaneplatinum II citrate 15 Methods 14 Blood Specimen Collection 14 fludarabine 13 Injections 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uterine Cervical Neoplasms × taxane × Clear all

NCT02624531 2021-01-07

SYSUGO-005

Sun Yat-sen University

Phase NA Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡